GlassScriptPhysician profile
Sandra N Koch
NPI 1760126304
$1,651.61
in general payments reported to CMS, 2019-2025
21 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.82 · 2024: $89.64 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,624.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $316.82 | 2025 | |
| Stryker Corporation | $224.02 | 2025 | Ortholoc 2 Lapifuse, Phalinx, Augment Injectable |
| Depuy Synthes Sales INC. | $214.23 | 2025 | Motoband, Na, N/A |
| Bone Support INC. | $133.36 | 2025 | Cerament G, Ceramentbone Void Filler |
| Peerless Surgical INC. | $111.39 | 2025 | |
| Integra Lifesciences Corporation | $80.02 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $79.01 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Globus Medical, INC. | $61.66 | 2025 | Senza |
| Medtronic, INC. | $57.12 | 2025 | Inceptiv |
| Smith+Nephew, INC. | $49.03 | 2025 | Stravix, Grafix Pl, Renasys Touch |
| Amgen INC. | $48.59 | 2024-2025 | Krystexxa |
| Bsn Medical INC | $41.56 | 2025 | |
| Convatec INC. | $41.25 | 2025 | |
| Tricoast Surgical Solutions LLC | $40.46 | 2024 | |
| Gramercy Extremity Orthopedics LLC | $36.90 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $23.36 | 2025 | Exogen Ultrasound Bone Healing System |
| Abbvie INC. | $22.67 | 2024 | |
| Averitas Pharma INC. | $19.94 | 2025 | Qutenza |
| Access Pro Medical, LLC | $19.85 | 2025 | Matriderm |
| Acera Surgical, INC. | $16.58 | 2025 | Restrata Wound Matrix |
| Paratek Pharmaceuticals, INC. | $13.79 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.